Arno Therapeutics, Inc.

ARNI · OTC
Analyze with AI
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Operating Activities
Net Income-$12$8-$40-$14
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$3
Stock-Based Comp.$3$5$1$1
Change in WC-$0-$2$1$1
Other Non-Cash-$2-$29$23$6
Operating Cash Flow-$10-$19-$14-$9
Investing Activities
PP&E Inv.$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$0$0$0
Investing Cash Flow$0-$0$0$0
Financing Activities
Debt Repay.$2-$0$0$15
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$11-$1
Financing Cash Flow$2-$0$30$14
Forex Effect$0$0$0$0
Net Chg. in Cash-$8-$19$16$4
Supplemental Information
Beg. Cash$8$27$11$7
End Cash$0$8$27$11
Free Cash Flow-$10-$19-$14-$9